Neuropeptide Y Y1 receptor effects on pulpal nociceptors

Journal of Dental Research

Volumn 87, Issue 10, 2008, Pages 948-952

  Gibbs, J L ^a,b   Harqreaves, K M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Capsaicin; Inflammation; NPY; Pain; Sympathetic; Y1

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; NEUROPEPTIDE Y RECEPTOR; TRPV1 PROTEIN, RAT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; INNERVATION; MALE; METABOLISM; NEUROGENIC INFLAMMATION; NOCICEPTIVE RECEPTOR; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TOOTH PAIN; TOOTH PULP; TRIGEMINUS GANGLION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DENTAL PULP; MALE; NEUROGENIC INFLAMMATION; NOCICEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; TOOTHACHE; TRIGEMINAL GANGLION; TRPV CATION CHANNELS;

EID: 58149263897     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910808701008     Document Type: Article

References (32)

1. Brain SD, Cox HM (2006). Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 147 (Suppl 1):202-211.
2. Brumovsky P, Shi TS, Landry M, Villar MJ, Hokfelt T (2007). Neuropeptide tyrosine and pain. Trends Pharmacol Sci 28:93-102.
3. Caviedes-Bucheli J, Lombana N, Azuero-Holguin MM, Munoz HR (2006). Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp. Int Endod J 39:394-400.
4. El Karim IA, Lamey PJ, Linden G.T, Awawdeh LA, Lundy FT (2006). Caries-induced changes in the expression of pulpal neuropeptide Y. Eur J Oral Sci 114:133-137.
5. Ericsson A, Hemsen A, Lundberg JM, Persson H (1991). Detection of neuropeptide Y-like immunoreaetivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp Cell Res 192:604-611.
6. Frislad I, Heyeraas KJ, Kvinnsland IH (1996). Neuropeptide Y expression in the trigeminal ganglion and mandibular division of the trigeminal nerve after inferior alveolar nerve axotomy in young rats. Exp Neurol 142:276-286.
7. Gibbs J, Flores CM, Hargreaves KM (2004). Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism. Neuroscience 125:703-709.
8. Gibbs JL, Flores CM, Hargreaves KM (2006). Attenuation of capsaicinevoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors. Pain 124:167-174.
9. Gibbs JL, Diogenes A, Hargreaves KM (2007). Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors. Br J Pharmacol 150:72-79.
10. Hargreaves KM, Bowles WR, Garry MG (1992). An in vitro method to evaluate regulation of neuropeptide release from dental pulp. J Endod 18:597-600.
11. Hargreaves KM, Bowles WR, Jackson DL (2003). Intrinsic regulation of CGRP release by dental pulp sympathetic fibers. J Dent Res 82:398-401.
12. Holliday NM, Michel MC, Cox HM (2004). NPY receptor subtypes and their signal transduction. In: Neuropeptide Y & related peptides. Michel MC, editor. Berlin: Springer-Verlag, pp. 45-74.
13. Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, et al. (2000). Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98:585-598.
14. Itotagawa T, Yamanaka H, Wakisaka S, Sasaki Y, Kato J, Kurisu K, et al. (1993). Appearance of neuropeptide Y-like imrnunoreactive cells in the rat trigeminal ganglion following dental injuries. Arch Oral Biol 38:725-728.
15. Jacobsen EB, Fristad I, Heyeraas KJ (1998). Nerve fibers imrnunoreactive to calcitonin gene-related peptide, substance P, neuropeptide Y, and dopamine beta-hydroxylase in innervated and denervated oral tissues in ferrets. Acta Odontol Scand 56:220-228.
16. Larhammar D (1996). Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 65:165-174.
17. Lin S, Boey D, Herzog H (2004). NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38:189-200.
18. Malmström RE (1997). Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. Acta Physiol Scand Suppl 636:1-55.
19. Mark MA, Colvin LA, Duggan AW (1998). Spontaneous release of immunoreactive neuropeptide Y from the central terminals of large diameter primary afferents of rats with peripheral nerve injury. Neuroscience 83:581-589.
20. Moran TD, Colmers WF, Smith PA (2004). Opioid-like actions of neuropeptide Y in rat substantia gelatinosa: Y1 suppression of inhibition and Y2 suppression of excitation. J Neurophysiol 92:3266-3275.
21. Ossipov MH, Zhang ET, Carvajal C, Gardell L, Quirion R, Dumont Y, et al (2002). Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. J Neurosci 22:9858-9867.
22. Oswald RJ, Byers MR (1993). The injury response of pulpal NPY-IR sympathetic fibers differs from that of sensory afferent fibers. Neurosci Lett 164:190-194.
23. Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Garnper N, Clarke WP, et al. (2005). Bradykinin-induccd functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 25:8825-8832.
24. Pohl M, Lombard MC, Bourgoin S, Carayon A, Benoliel JJ, Mauborgne A, et al. (1989). Opioid control of the in vitro release of calcitonin generelated peptide from primary afferent fibres projecting in the rat cervical cord. Neuropeptides 14:151-159.
25. Ubink R, Hokfelt T (2000). Neuropeptide Y expression in Schwann cell precursors. Glia 32:71-83.
26. Uddman R, Grunditz T, Sundler F (1984). Neuropeptide Y: occurrence and distribution in dental pulps. Acta Odontol Scand 42:361-365.
27. Ulrich-Lai YM, Flores CM, Harding-Rose CA, Goodis HE, Hargreaves KM (2001). Capsaicin-evokcd release of immunoreactive calcitonin gene-related peptide from rat trigeminal ganglion: evidence for intraganglionic neurotransmission. Pain 91:219-226.
28. Wakisaka S, Kajander K.C, Bennett GJ (1991). Increased neuropeptide Y (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci Lett 124:200-203.
29. Wakisaka S, Youn SH, Kato J, Takemura M, Kurisu K. (1996). Neuropeptide Y-immunoreactive primary afferents in the dental pulp and periodontal ligament following nerve injury to the inferior alveolar nerve in the rat. Brain Res 712:11-18.
30. Wheway J, Herzog H, Mackay F (2007). NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem 7:1743-1752.
31. Zhang X, Bao L, Xu ZQ, Kopp J, Arvidsson U, Elde R, et al. (1994). Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons. Proc Natl Acad Sci USA 91:11738-11742.
32. Zhang X, Shi T, Flolmberg K, Landry M, Huang W, Xiao H, et al. (1997). Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proc Natl Acad Sci USA 94:729-734.